TMCnet News
Apixio Earns Coveted Spot on Deloitte's 2019 Technology Fast 500 List of Fastest Growing Companies in North AmericaSAN MATEO, Calif., Nov. 7, 2019 /PRNewswire/ -- Apixio Inc., the AI healthcare analytics company, today announced it has ranked number 227 on the Deloitte Technology Fast 500™, a list of the fastest-growing companies in North America. The recognition comes as Apixio celebrates 10 years of driving innovation in healthcare data analytics with its market-leading AI platform that turns unstructured text from clinical documents into actionable insights. The Apixio Platform's proprietary AI algorithms surface targeted intelligence that supports providers and plans as they move toward outcomes-based care delivery models. "There is tremendous potential to transform our healthcare system by more effectively utilizing the 1.2 billion clinical documents created every year, most of which currently goes unused in the management of care," said Apixio CEO Darren Schulte, M.D. "Since day one, we've worked to unlock that potential through artificial intelligence. This recognition by Deloitte is strong validation of our success in improving the cost and quality of care with data-driven solutions, and we're excited to apply this same technology to clinical phenotyping and appropriateness of care as we look to the future."
In order to be eligible for Technology Fast 500 recognition, companies must own proprietary intellectual property or technology that is sold to customers in products that contribute to a majority of the company's operating revenues. Additionally, companies must be in business for a minimum of four years and be headquartered within North America. To learn more about Apixio's AI healthcare analytics solutions, visit www.apixio.com. About Apixio About Deloitte MEDIA CONTACT:
View original content to download multimedia:http://www.prnewswire.com/news-releases/apixio-earns-coveted-spot-on-deloittes-2019-technology-fast-500-list-of-fastest-growing-companies-in-north-america-300953908.html SOURCE Apixio, Inc. |